High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the I kappa B kinase alpha pathway in response to extracellular NaCl content.
Increasing evidence suggests that in airways from cystic fibrosis (CF) patients, inflammation may precede bacterial infection and be related to an endogenous dysregulation of proinflammatory cytokines in airway epithelial cells. Several investigators have reported that, in CF airway fluids, elevated NaCl concentrations may also contribute to the diseased state by inhibiting the bactericidal properties of airway fluid. Because many proinflammatory cytokines are transcriptionally regulated by the NF-kappa B, we investigated whether an elevated extracellular NaCl content in airway fluids significantly impaired the regulation of the NF-kappa B/I kappa B alpha complex and the chemokine IL-8 production in primary non-CF and CF human bronchial gland epithelial cells. Exposure of non-CF gland cells to hypotonic (85 mM) NaCl solution, compared with isotonic (115 mM) NaCl and hypertonic (170 mM) NaCl solutions, resulted in a significant decrease in IL-8 production that was paralleled by a strong inhibition of activated NF-kappa B associated with an increased cytosolic expression of I kappa B alpha and a decrease in the I kappa B kinase alpha protein level. In CF gland cells, we demonstrated that, compared with the high IL-8 in an hypertonic solution, the release of IL-8 was significantly reduced 2-fold in an isotonic solution and 5-fold in a hypotonic solution. Strikingly, exposure of CF bronchial gland cells to either hypotonic or isotonic milieu did not result in a marked inhibition of the activated NF-kappa B/I kappa B alpha system. This is the first demonstration that primary human CF bronchial gland cells exhibit abnormally high IL-8 production through constitutively activated NF-kappa B and high I kappa B kinase alpha level, whatever the hypo-, iso-, and hypertonic NaCl milieu.
Tabary
O
O
Institut National de la Santé et de la Recherche Médicale, Unité 514, Institut Fédératif de Recherche 53, Centre Hospitalier Universitaire, Maison Blanche, Reims, France.
Escotte
S
S
Couetil
J P
JP
Hubert
D
D
Dusser
D
D
Puchelle
E
E
Jacquot
J
J
D000293:Adolescent; D000328:Adult; D001980:Bronchi / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D002478:Cells, Cultured; D002648:Child; D003550:Cystic Fibrosis / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism* / Q000473:pathology; D005110:Extracellular Space / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D051550:I-kappa B Kinase; D016209:Interleukin-8 / Q000096:biosynthesis* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000096:biosynthesis; D017346:Protein Serine-Threonine Kinases / Q000096:biosynthesis / Q000502:physiology*; D020545:Respiratory Mucosa / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D012965:Sodium Chloride / Q000378:metabolism* / Q000494:pharmacology
D016209:Interleukin-8; D016328:NF-kappa B; D012965:Sodium Chloride; D017346:Protein Serine-Threonine Kinases; C496559:CHUK protein, human; D051550:I-kappa B Kinase; C496560:IKBKB protein, human; C496565:IKBKE protein, human